Atrial Natriuretic Peptide and Circadian Blood Pressure Regulation: Clues from a Chronobiological Approach

References

• Richards AM, McDonald D, Fitzpatrick MA, et al. Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations. J Clin Endocrinol McTab 1988; 67: 1134–9
   PubMed Web of Science ®Google Scholar
• Brown J, O'Flynn MA. Acute effects of physiological increments of atrial natriuretic peptide in man. Kidney Int 1989; 36: 645–52
   PubMed Web of Science ®Google Scholar
• Bruun NE, Skøett P, Giese J. Renal and endocrine effects of physiological variations of atrial natriuretic factor in man. Am J Physiol 1991; 260: R217–24
   Google Scholar
• Richards AM, Espiner EA, Ikram H, Yandle TG. Atrial natriuretic factor in hypertension: bioactivity at normal plasma levels. Hypertension 1989; 14: 261–8
   PubMed Web of Science ®Google Scholar
• Janssen WM, de Zeeuw D, van der Hem GK, de Jong PE. Antihypertensive effect of a 5-day infusion of atrial natriuretic factor in humans. Hypertension 1989; 13: 640–6
   PubMed Web of Science ®Google Scholar
• Cusson JR, Thibault G, Cantin M, Larochelle P. Prolonged low dose infusion of atrial natriuretic factor in essential hypertension. Clin Exp Hypertens [A] 1990; 12: 111–35
   PubMed Web of Science ®Google Scholar
• Bruun NE, Skøtt P, Giese J. Renal sites of action of physiological increases in plasma atrial natriuretic factor concentration in essential hypertension. J Hypertens 1992; 10: 37–47
   Google Scholar
• Franco-Saenz R, Somani P, Mulrow PJ. Effect of atrial natriuretic peptide (8–33-Met ANP) in patients with hypertension. Am J Hypertens 1992; 5: 266–75
   Google Scholar
• Hildebrandt DA, Mizelle HL, Brands MW, Gaillard CA, Smith MJ, Jr, Hall J. Intrarenal atrial natriuretic peptide infusion lowers arterial pressure chronically. Am J Physiol 1990; 259: R585–92
   Google Scholar
• Gaillard CA, Mizelle HL, Montani JP, Brands MW, Hildebrandt DA, Hall JE. Atrial natriuretic factor and blood pressure control: role of sodium and aldosterone. Am J Physiol 1990; 259: R973–80
   Google Scholar
• Parkes DG, Coghlan JP, McDougall JG, Scoggins BA. Long-term hemodynamic actions of atrial natriuretic factor (99–126) in conscious sheep. Am J Physiol 1988; 254: H811–5
   PubMed Web of Science ®Google Scholar
• Garcia R, Thibault G, Gutkowska J, et al. Chronic infusion of low doses of atrial natriuretic Factor (ANF Arg 101-Tyr 126) reduces blood pressure in conscious SHR without apparent changes in sodium excretion. Proc Soc Exp Biol Med 1985; 179: 396–401
   PubMed Web of Science ®Google Scholar
• Fluckiger JP, Deghenghi R, Waeber B, Immer HU, Nussberger J, Brunner HR. Effects of dextrona-trin on blood pressure, hematocrit, urinary sodium excretion and sympathetic nerve activity of rats. Fundam Clin Pharmacol 1990; 4: 129–39
   Google Scholar
• Fenoy FJ, Quesada JT, Garcia-Salom M, Romero JC, Salazar FJ. Hemodynamic effects of chronic infusion of ANP in renal hypertensive rats. Am J Physiol 1989; 256: H1393–8
   Google Scholar
• Weidman P, Gnädinger MP, Ziswiler HR, et al. Cardiovascular, endocrine and renal effects of atrial natriuretic peptide in essential hypertension. J Hypertens 1986; 4(suppl 2)S71–83
   Google Scholar
• Cusson JR, Hamet P, Gutkowska J, et al. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension. J Hypertens 1987; 5: 435–43
   PubMed Web of Science ®Google Scholar
• Bruun NE, Nielsen MD, Skøtt P, et al. Changes in cyclic guanosine monophosphate atrial natriuretic factor relationship in hypertensive man. J Hypertens 1989; 7: 287–91
   PubMedGoogle Scholar
• Guyton AC. Arterial pressure and hypertension. WB Saunders, Philadelphia 1980
   Google Scholar
• Takezawa K, Cowley AW, Jr, Skelton M, Roman RJ. Atriopeptin II alters renal medullary hemodynamics and the pressure-diuresis response in rats. Am J Physiol 1987; 252: F992–1002
   PubMed Web of Science ®Google Scholar
• Paul RV, Kirk KA, Navar LG. Renal autoregulation and pressure natriuresis during ANP-induced diuresis. Am J Physiol 1987; 253: F424–31
   PubMed Web of Science ®Google Scholar
• Mizelle HL, Hall JE, Hildebrandt DA. Atrial natriuretic peptide and pressure natriuresis: interactions with the renin-angiotensin system. Am J Physiol 1989; 257: R1169–74
   PubMed Web of Science ®Google Scholar
• Mizelle HL, Hildebrandt DA, Gaillard CA, et al. Atrial natriuretic peptide induces sustained natriuresis in conscious dogs. Am J Physiol 1990; 258: R1445–52
   Google Scholar
• Sosa RE, Volpe M, Marion DN, et al. Relationship between renal hemodynamic and natriuretic effects of atrial natriuretic factor. Am J Physiol 1986; 250: F520–4
   PubMed Web of Science ®Google Scholar
• Burnett JC, Jr, Granger JP, Opgenorth TJ. Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol 1984; 247: F863–6
   PubMed Web of Science ®Google Scholar
• Maack T, Marion DN, Camargo M JF, et al. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med 1984; 77: 1069–75
   PubMed Web of Science ®Google Scholar
• Scheuer DA, Thrasher TN, Quillen EW, Jr, Metzler CH, Ramsay DJ. Atrial natriuretic peptide blocks renin response to renal hypotension. Am J Physiol 1987; 251: R423–7
   Google Scholar
• Metzler CH, Ramsay DJ. Physiological doses of atrial peptide inhibit angiotensin II-stimulated aldosterone secretion. Am J Physiol 1989; 256: R1155–9
   PubMed Web of Science ®Google Scholar
• Cuneo RC, Espiner EA, Nicholls MG, Yandle TG, Livesey JH. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man. J Clin Endocrinol Metab 1987; 65: 765–72
   PubMed Web of Science ®Google Scholar
• Richards AM, Tonolo G, Montorsi P, et al. Low dose infusions of 26- and 28-amino acid human atrial natriuretic peptides in normal man. J Clin Endocrinol Metab 1988; 66: 465–72
   PubMedGoogle Scholar
• Cameron VA, Espiner EA, Nicholls MG, Skidmore DS. Hormone and hernodynamic responses to atrial natriuretic peptide in conscious sheep and effect of hemorrhage. Endocrinology 1988; 122: 407–14
   PubMed Web of Science ®Google Scholar
• Granger JP, Opgenorth TJ, Salazar J, Romero JC, Burnctt JC, Jr. Long-term hypotensive and renal effects of atrial natriuretic peptide. Hypertension 1986; 8(suppl 2)112–6
   Google Scholar
• Garcia R, Thibault G, Cantin M, Genest J. Effect of purified atrial natriuretic factor on rat and rabbit vascular strips and vascular beds. Am J Physiol 1984; 247: R34–9
   PubMed Web of Science ®Google Scholar
• Kleinert HD, Maack T, Atlas SA, Januszewicz J, Sealey JE, Laragh JH. Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility. Hypertension 1984; 6(suppl 1)143–7
   Google Scholar
• Harris PJ, Thomas D, Morgan TO. Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption. Nature 1987; 326: 696–8
   Google Scholar
• Nicolantonio RD, Stevens J, Weaver D, Morgan TO. Captopril antagonizes the hypotensive action of atrial natriuretic peptide in anesthetized rat. Clin Exp Pharmacol Physiol 1986; 13: 311–4
   Google Scholar
• Yasujima M, Abe K, Kohzuki M, et al. Effect of atrial natriuretic factor on angiotensin II-induced hypertension in rats. Hypertension 1986; 8: 748–53
   Google Scholar
• Lee RW, Goldman S. Mechanism for decrease in cardiac output with atrial natriuretic peptide in dogs. Am J Physiol 1989; 256: H760–5
   PubMed Web of Science ®Google Scholar
• Ebert TJ. Reflex activation of sympathetic nervous system by ANF in humans. Am J Physiol 1988; 255: H685–9
   Google Scholar
• Thoren P, Mark AL, Morgan DA., O'Neill T, Needleman P.P, Brody MJ. Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activity. Am J Physiol 1986; 251: H1252–9
   PubMed Web of Science ®Google Scholar
• Hirooka Y, Takeshita A, Imaizumi T, Nakamura N, Tomoike H, Nakarnura M. Effects of alpha-human atrial natriuretic peptide on the interrelationship of arterial pressure, aortic nerve activity, and aortic diameter. Circ Res 1988; 63: 987–96
   PubMed Web of Science ®Google Scholar
• Kuchel O, Debinski W, Buu NT, Cantin M, Genest J. Ganglionic immunoreactive atrial natriuretic factor in rat experimental hypertension. Hypertension 1988; 11: 147–51
   Google Scholar
• Imam K, Maddens M, Mohanty PK, Felicetta JV, Sowers JR. Atrial natriuretic peptide attenuates the reflex sympathetic responses to lower body negative pressure. Am J Med Sci 1989; 298: 1–7
   Google Scholar
• Giles TD. Defining the role of atrial natriuretic factor in health and disease. J Am Coll Cardiol 1990; 15: 1331–3
   Google Scholar
• Ferrari AU, Daffonchio A, Sala C, Gerosa S, Mancia G. Atrial natriuretic factor and arterial barore-ceptor reflexes in unanesthetized rats. Hypertension 1990; 15: 162–7
   Google Scholar
• Takeshita A. Effects of atrial natriuretic factor on baroreceptor reflexes. Hypertension 1990; 15: 168–9
   Google Scholar
• Kurihara M, Saavedra JM, Shigematsu K. Localization and characterization of atrial natriuretic peptide binding sites in discrete areas of rat brain and pituitary gland by quantitative autoradiography. Brain Res 1987; 408: 31–9
   Google Scholar
• Levin ER, Frank HJ, Weber MA, Ismail M, Mills S. Studies of the penetration of the blood brain barrier by atrial natriuretic factor. Biochem Biophys Res Commun 1987; 147: 1226–31
   PubMed Web of Science ®Google Scholar
• Saper CB, Standaert DG, Currie MG, Schwartz D, Geller DM, Needleman P. Atnopeptin-immunore-active neurons in the brain: presence in cardiovascular regulatory areas. Science 1985; 227: 1047–9
   PubMed Web of Science ®Google Scholar
• Skofitsch G, Jacobowitz DM., Eskay RL, Zamir N. Distribution of atrial natriuretic factor-like immunoreactive neurons in the rat brain. Neuroscience 1985; 16: 917–48
   PubMed Web of Science ®Google Scholar
• Ruskoaho H, Leppaluoto J. lmmunoreactive atrial natriuretic peptide in ventricles, atria. hypothalamus, and plasma of genetically hypertensive rats. Circ Res 1988; 62: 384–94
   PubMed Web of Science ®Google Scholar
• Levin ER, Weber MA, Mills S. Atrial natriuretic factor-induced vasodepression occurs through central nervous system. Am J Physiol 1988; 255: H616–22
   Google Scholar
• Mullally DF, Brosnihan K, Diz B. DI. Cardiovascular actions of intrahypothalamic injections of atrial natriuretic peptide. Peptides 1989; 10: 1081–7
   Google Scholar
• Palkovits M, Geiger H, Bahner U, Fodor M, Pammer C. Atrial natriuretic factor in central nervous system regulatory mechanisms: effect of experimental alterations in water and salt homeostasis and blood pressure. Miner Electrolyte Metab 1990; 16: 42–7
   Google Scholar
• Fujio N, Ohashi M, Nawata H, et al. Alpha-human atrial natriuretic polypeptide reduces the plasma arginine vasopressin concentration in human subjects. Clin Endocrinol 1986; 25: 181–7
   PubMedGoogle Scholar
• Standaert DG, Cechetto DF, Needleman P, Saper CB. Inhibition of the firing of vasopressin neurons by atriopeptin. Nuture 1987; 329: 151–3
   PubMedGoogle Scholar
• Yoshida K, Kawano Y, Kawamura M, Kuramochi M, Omae T. Effects of intracerebroventricular atrial natriuretic factor on angiotensin II- or sodium-induced blood pressure elevation and natriure-sis. J Hypertens 1989; 7: 639–43
   Google Scholar
• Al-Barazanji KA, Balment RJ. The renal and vascular effects of central angiotensin II and atrial natriuretic factor in the anaesthetized rat. J Physiol 1990; 423: 485–93
   Google Scholar
• Makino S, Hashimoto K, Hirasawa R, Hattori T, Ota Z. Central interaction between endothelin and brain natriuretic peptide on vasopressin secretion. J Hypertens 1992; 10: 25–8
   Google Scholar
• Bates ER, Shenker Y, Grekin RJ. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hernodynamic function in man. Circulation 1986; 73: 1155–61
   PubMed Web of Science ®Google Scholar
• Hollister AS, Inagami T. Atrial natriuretic factor and hypertension. A review and metaanalysis. Am J Hypertens 1991; 4: 850–65
   PubMedGoogle Scholar
• Widgren BR, Hedner T, Hedner J, Berglund G, Wikstrand J, Andersson OK. Resting and volume-stimulated circulating atrial natriuretic peptide in young norniotensive men with positive family histories of hypertension. J Hypertens 1991; 9: 139–46
   PubMed Web of Science ®Google Scholar
• Shenker Y, Sider RS, Ostafin EA, Grekin RJ. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. J Clin Invest 1985; 76: 1684–7
   PubMed Web of Science ®Google Scholar
• Burnett J CJ, Kao PC, Hu DC, et al. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 1986; 231: 1145–7
   PubMed Web of Science ®Google Scholar
• Arendt RM, Gerbes AL, Ritter D, Stangl E, Bach P, Zahringer J. Atrial natriuretic factor in plasma of patients with arterial hypertension. heart failure or cirrhosis of the liver. J Hypertens 1986; 4(suppl 2)S131–5
   Google Scholar
• Pettersson A, Hedner J, Hedner T, Held P, Swedberg K, Towle AC. Increased plasma levels of atrial natriuretic peptide in patients with congestive heart failure. Eur Heart J 1986; 7: 693–6
   PubMed Web of Science ®Google Scholar
• Raine AE, Erne P, Burgisser E, et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 1986; 315: 533–7
   PubMed Web of Science ®Google Scholar
• Schiffrin EL, Taillefer R. Correlation of left ventricular ejection fraction and plasma atrial natriuretic peptide in congestive heart failure [Letter]. N Engl J Med 1986; 315: 765–6
   PubMed Web of Science ®Google Scholar
• Hara H, Ogihara T, Shima J, et al. Plasma atrial natriuretic peptide level as an index for the severity of congestive heart failure. Clin Cardiol 1987; 10: 437–42
   PubMed Web of Science ®Google Scholar
• Cody RJ, Atlas SA, Laragh JH, et al. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest 1986; 78: 1362–74
   PubMed Web of Science ®Google Scholar
• Webster MW, Sharpe DN, Coxon R, et al. Effect of reducing atrial pressure on atrial natriuretic factor and vasoactive hormones in congestive heart failure secondary to ischemic and nonischemic dilated cardiomyopathy. Am J Cardiol 1989; 63: 217–21
   PubMed Web of Science ®Google Scholar
• Riegger AJ. Interaction between atrial natriuretic peptide. renin system and vasopressin in heart failure. Eur Heart J 1990; 11(suppl B)79–83
   Google Scholar
• Edwards BS, Ackermann DM, Lee ME, Reeder GS, Wold LE, Burnett J CJ. Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestize heart Failure. J Clin Invest 1988; 81: 82–6
   PubMed Web of Science ®Google Scholar
• Franch HA, Dixon RA, Blaine EH, Siegl PK. Ventricular atrial natriurctic factor in the cardiomyopathic hamster model of congestive heart failure. Circ Res 1988; 62: 31–6
   PubMed Web of Science ®Google Scholar
• Cantin M, Thibault G, Ding JF, et al. ANF in experimental congestive heart failure. Am J Pathol 1988; 130: 552–68
   PubMed Web of Science ®Google Scholar
• Drexler H, Hanze J, Finckh M, Lu W, Just H, Lang RE. Atrial natriuretic peptide in a rat model of cardiac failure. Atrial and ventricular mRNA, atrial content, plasma levels, and effect of volume loading. Circiilation 1989; 79: 620–33
   PubMed Web of Science ®Google Scholar
• Thibault G, Nemer M, Drouin J, et al. Ventricles as a major site of atrial natriuretic factor synthesis and release in cardiomyopathic hamsters with heart failure. Circ Res 1989; 65: 71–82
   PubMed Web of Science ®Google Scholar
• Arbustini E, Pucci A, Grasso M, et al. Expression of natriuretic peptide in ventricular myocardium of failing human hearts and its correlation with the severity of clinical and hemodynamic impairment. Am J Cardiol 1990; 66: 973–80
   PubMed Web of Science ®Google Scholar
• Tsunoda K, Hodsman GP, Sumithran E, Johnston CI. Atrial natriuretic peptide in chronic heart failure in the rat: a correlation with ventricular dysfunction. Circ Res 1986; 59: 256–61
   PubMed Web of Science ®Google Scholar
• Ding J, Thibault G, Gutkowska J, et al. Cardiac and plasma atrial natriuretic factor in experimental congestive heart failure. Endocrinology 1987; 121: 248–57
   PubMed Web of Science ®Google Scholar
• Sugawara A, Nakao K, Morii N, et al. Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP. J Clin Invest 1988; 81: 1962–70
   PubMed Web of Science ®Google Scholar
• Kojima S, Inoue I, Hirata Y, et al. Plasma concentrations of immunoreactive atrial natriuretic polypeptide in patients on hemodialysis. Nephron 1987; 46: 45–8
   PubMed Web of Science ®Google Scholar
• Walker RG, Swainson CP, Yandle TG, Nicholls MG, Espiner EA. Exaggerated responsiveness of immunoreactive atrial natriuretic peptide to saline infusion in chronic renal failure. Clin Sci 1987; 72: 19–24
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Higa T, Kitamura K, Tanaka K, Kangawa K, Matsuo H. Plasma concentration of human atrial natriuretic polypeptide in patients with impaired renal function. Clin Nephrol 1987; 27: 84–6
   PubMed Web of Science ®Google Scholar
• Suda S, Weidmann P, Saxenhofer H, Cottier C, Shaw SG, Femer C. Atrial natriuretic factor in mild to moderate chronic renal failure. Hypertension 1988; 11: 483–90
   PubMed Web of Science ®Google Scholar
• Doorenbos CJ, Daha MR, van Brummelen P. Correlates of plasma atrial natriuretic peptide levels in renal transplant recipients. Clin Nephrol 1989; 31: 146–9
   Google Scholar
• Predel HG, Kipnowski J, Meyer-Lehnert H, Arendt RM, Kramer HJ. Human atrial natriuretic peptide in non-dialyzed patients with chronic renal failure. Clin Nephrol 1989; 31: 150–5
   Google Scholar
• Raine AE, Bock A, Muller FB, et al. Comparative effects of haemodialysis and haemofiltration on plasma atrial natriuretic peptide. Nephrol Dial Transplant 1989; 4: 222–7
   PubMed Web of Science ®Google Scholar
• Saxenhofer H, Gnadinger MP, Weidmann P, et al. Plasma levels and dialysance of atrial natriuretic peptide in terminal renal failure. Kidney Int 1987; 32: 554–61
   PubMedGoogle Scholar
• Shenker Y, Port F, Swartz R, Gross M, Grekin R. Atrial natriuretic hormone secretion in patients with renal failure. Life Sci 1987; 41: 1635–44
   Google Scholar
• Theodorsson E. Regulatory peptides in renal failure: effects and possible pathophysiological role. Int J Artif Organs 1990; 13: 149–61
   Google Scholar
• Shaw SG, Weidmann P, Saxenhofer H. Atrial natriuretic factor, renal failure and hemodialysis. Int J Artif Organs 1990; 13: 138–44
   Google Scholar
• Jahn H, Schohn D, Schmitt R. Hernodynamic studies in chronic terminal renal insufficiency. Effects of hemodialysis, hemofiltration and ultrafiltration procedures. Nephrologie 1981; 2: 53–62
   Google Scholar
• Ando R, Matsuda O, Miyake S, Yoshiyama N. Plasma levels of human atrial natriuretic factor in patients treated by hemodialysis and continuous ambulatory peritoneal dialysis. Nephron 1988; 50: 225–8
   PubMed Web of Science ®Google Scholar
• Kurokawa S, Katoh Y, Sugiyama T, et al. Correlation of decreased plasma atrial natriuretic peptide level with left atrial diameter in chronic hemodialysis [Letter]. Am J Curdiol 1987; 60: 1135
   Google Scholar
• Petersen J, Li CC, Bishop-Abney N, Seniw CM. Hemodynamic and atrial natriuretic peptide responses to fluid removal and reinfusion in hernodialysis patients. ASAIO Trans 1988; 34: 509–11
   Google Scholar
• Morissey EC, Wilner KD, Barager RR, Ward DM, Ziegler MG. Atrial natriuretic factor in renal failure and posthemodialytic postural hypotension. Am J Kidney Dis 1988; 12: 510–5
   Google Scholar
• Donckier J, Anderson JV, Yeo T, Bloom SR. Diurnal rhythm in the plasma concentration of atrial natriuretic peptide [Letter]. N Engl J Med 1986; 315: 710–1
   PubMed Web of Science ®Google Scholar
• Richards AM, Tonolo G, Fraser R, et al. Diurnal change in plasma atrial natriuretic peptide concentrations. Clin Sci 1987; 73: 489–95
   Web of Science ®Google Scholar
• Winters CJ, Sallman AL, Vesely DL. Circadian rhythm of prohormone atrial natriuretic peptides 1–30, 31–67 and 99–126 in man. Chronobiol Int 1988; 5: 403–9
   PubMed Web of Science ®Google Scholar
• McCance DR, Roberts G, Sheridan B, et al. Variations in the plasma concentration of atrial natriuretic factor across 24 hours. Acta Endocrinol 1989; 120: 266–70
   PubMedGoogle Scholar
• Colantonio D, Pasqualetti P, Casale R, Natali G. Is atrial natriuretic peptide important in the circadian rhythm of arterial blood pressure? [Letter]. Am J Cardiol 1989; 63: 1166
   PubMed Web of Science ®Google Scholar
• Miyamoto S, Shimokawa H, Sumioki H, Touno A, Nakano H. Physiologic role of endogenous human atrial natnuretic peptide in preeclamptic pregnancies. Am J Obstet Gynecol 1989; 160: 155–9
   PubMed Web of Science ®Google Scholar
• Sumioki H, Shimokawa H, Miyamoto S, Uezono K, Utsunomiya T, Nakano H. Circadian variations of plasma atrial natriuretic peptide in four types of hypertensive disorder during pregnancy. Br J Obstet Gynaecol 1989; 96: 922–7
   PubMedGoogle Scholar
• Portaluppi F, Montanan L, Bagni B, degli Uberti E, Trasforini G, Margutti A. Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects. Cardiology 1989; 76: 428–32
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Bagni B, degli Uberti E, et al. Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects. J Hypertens 1990; 8: 85–95
   PubMed Web of Science ®Google Scholar
• Watanabe T, Uchiyama Y. Quantitative analyses of atrial myoendocrine cells and plasma atrial natriuretic peptides (ANP) of the rat with special reference to the twenty-four-hour variations in secretory granules and plasma ANP concentrations. Cell Tissue Res 1988; 254: 133–7
   PubMed Web of Science ®Google Scholar
• Weil J, Strom TM, Heim JM, et al. Influence of diurnal rhythm, posture and right atrial size on plasma atrial natriuretic peptide levels. Z Kurdiol 1988; 77(suppl 2)36–40
   PubMedGoogle Scholar
• Heber ME, Lahiri A, Thompson D, Raftery EB. Baroreceptor, not left ventricular, dysfunction is the cause of hemodialysis hypotension. Clin Nephrol 1989; 32: 79–86
   PubMedGoogle Scholar
• Baumgart P, Walger P, Gerke M, Dorst KG, Vetter H, Rahn KH. Nocturnal hypertension in renal failure, haemodialysis and after renal transplantation. J Hypertens 1989; 7(suppl 6)S70–1
   Google Scholar
• Middeke M, Mika E, Schreiber MA, Beck B, Wachter B, Holzgreve H. Ambulante indirekte Blut-drucklangzeitmessung bei primarer und sekundarer Hypertonie. Klin Wochenschr 1989; 67: 713–6
   PubMedGoogle Scholar
• Portaluppi F, Montanari L, Massari M, Di Chiara V, Capanna M. Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure. Am J Hypertens 1991; 4: 20–6
   PubMed Web of Science ®Google Scholar
• Rosansky SJ. Nocturnal hypertension in patients receiving chronic hemodialysis [Letter]. Am Intern Med 1991; 114: 96
   Google Scholar
• Portaluppi F, Montanan L, Vergnani L, et al. Loss of the nocturnal increase in plasma concentration of atrial natriuretic peptide in hypertensive chronic renal failure. Cardiology 1992; 80: 312–23
   PubMed Web of Science ®Google Scholar
• Furlan R, Guzzetti S, Crivellaro W, et al. Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation 1990; 81: 537–47
   PubMed Web of Science ®Google Scholar
• Clement DL, De Pue N, Jordaens LJ, Packet L. Adrenergic and vagal influences on blood pressure variability. Clin Exp Hypertens [A] 1985; 7: 159–66
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Pradella A, Montanari L, et al. Atrial strain is the main determinant of release of atrial natriuretic peptide. Int J Cardiol 1990; 29: 297–303
   PubMed Web of Science ®Google Scholar
• Petterson A, Ricksten S, Towle AC, Hedner J, Hedner T. Effect of blood volume expansion and sympathetic denervation on plasma level of atrial natriuretic factor (ANF) in the rat. Acta Physiol Scand 1985; 124: 309–11
   PubMedGoogle Scholar
• Currie MG, Newman WH. Evidence for alpha-1 adrenergic receptor regulation of atriopeptin release from isolated rat heart. Biochem Biophys Res Commun 1986; 137: 94–100
   PubMed Web of Science ®Google Scholar
• Eskay R, Zukowska-Grojec Z, Haass M, Dave J RD, Zamir N. Circulating atrial natriuretic peptides in conscious rats: regulation of release by multiple factors. Science 1986; 232: 636–9
   PubMed Web of Science ®Google Scholar
• Rankin AJ, Wilson N, Ledsome JR. Influence of isoprotercnol on plasma immunoreactive atrial natriuretic peptide and plasma vasopressin in the anesthetized rabbit. Pflugers Arch 1987; 408: 124–8
   Google Scholar
• Pruszczynski W, Viron B, Czekalski S, Mignon F, Ardaillou R. Role of cardiac parasympathetic dysfunction in atrial natriuretic peptide response to volume changes in patients with chronic renal failure. Miner Electrolyte Metab 1987; 13: 333–9
   PubMedGoogle Scholar
• Volpe M, De Luca N, Atlas SA, et al. Reduction of atrial natriuretic factor circulating levels by endogenous sympathetic activation in hypertensive patients. Circulation 1988; 77: 997–1002
   PubMed Web of Science ®Google Scholar
• Armbruster H, Vetter W, Beckcrhoff R, Nussberger J, Vetter H, Siegenthaler W. Diurnal variations of plasma aldosterone in supine man. Relationship to plasma renin activity and plasma cortisol. Acta Endocrinol 1975; 80: 95–103
   PubMedGoogle Scholar
• Katz FH, Romfh P, Smith JA. Diurnal variations of plasma aldosterone, cortisol and renin activity in supine man. J Clin Endocrinol Metab 1975; 40: 125–34
   PubMed Web of Science ®Google Scholar
• degli Uberti EC, Fabbri BL, Margutti AR, Fersini CM, Pansini R. Effect of bromocriptine on the control of plasma aldosterone diurnal variation in normal supine man. Hormone Res 1979; 10: 64–78
   PubMedGoogle Scholar
• Trasforini G, Margutti A, Portaluppi F, et al. Circadian profile of plasma calcitonin generelated peptide in healthy man. J Clin Endocrinol Metab 1991; 73: 945–51
   PubMed Web of Science ®Google Scholar
• Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and nondippers. Circulation 1990; 81: 700–2
   PubMed Web of Science ®Google Scholar
• Lilley JJ, Golden J, Stone RA. Adrenergic regulation of blood pressure in chronic renal failure. J Clin lnvest 1976; 24: 1190–200
   Google Scholar
• Zoccali C, Ciccarelli M, Magiore Q. Defective reflex control of heart rate in dialysis patients: evidence for an afferent autonomic lesion. Clin Sci 1982; 63: 285–92
   PubMed Web of Science ®Google Scholar
• Solders G, Persson A, Gutierrez A. Autonomic dysfunction in nondiabetic terminal uremia. Acta Neurol Scand 1985; 71: 321–7
   PubMed Web of Science ®Google Scholar
• Yoshino F, Sakuma N, Date T, et al. Diurnal change of plasma atrial natriuretic peptide concentrations in patients with congestive heart failure. Am Heart J 1989; 117: 1316–9
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Montanan L, Ferlini M, et al. Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure. Chronobiol Int 1991; 8: 432–9
   PubMed Web of Science ®Google Scholar
• Caruana MP, Lahiri A, Cashman PM, Altman DG, Raftery EB. Effects of chronic congestive heart failure secondary to coronary artery disease on the circadian rhythm of blood pressure and heart rate. Am J Cardiol 1988; 62: 755–9
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Montanari L, Ferlini M, Vergnani L, Bagni B, degli Uberti E. Differences in blood pressure regulation of congestive heart failure before and after treatment correlate with changes in the circulating pattern of atrial natriuretic peptide. Eur Heart J 1992; 13: 990–6
   PubMed Web of Science ®Google Scholar
• Riegger GA, Elsner D, Kromer EP, et al. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects. Circulation 1988; 77: 398–406
   PubMed Web of Science ®Google Scholar
• Maack T, Suzuki M, Almeida F, et al. Physiological role of silent receptors of atrial natriuretic factor. Science 1987; 238: 675–8
   PubMed Web of Science ®Google Scholar